Showing results (51-60 of 54) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Blood Advances|October 13, 2021
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphomaPier Luigi Zinzani, Radhakrishnan Ramchandren, Armando Santoro, et al.Seminars in Hematology|May 17, 2025
Report of Consensus Panel 4 from the 12th International Workshop on Waldenström's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphomaAlessandra Tedeschi, Rebecca Auer, Francesco Autore, et al.Journal of Chemotherapy (Florence, Italy)|October 16, 2014
Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphomaMisato Kikuchi, Hideki Nakasone, Yu Akahoshi, et al.The Lancet. Oncology|March 15, 2021
Pembrolizumab versus brentuximab vedotin in relapsed or refractory classical Hodgkin lymphoma (KEYNOTE-204): an interim analysis of a multicentre, randomised, open-label, phase 3 studyJohn Kuruvilla, Radhakrishnan Ramchandren, Armando Santoro, et al.Pageof 6